1)外園千恵:SJSとTENの眼合併症.玉置邦彦(総編):最新皮膚科学体系2008-2009.中山書店,pp 182-188,2008
2)Araki Y, Sotozono C, Inatomi T et al:Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol 147:1004-1011, 2009
3)Sotozono C, Ueta M, Koizumi N et al:Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 116:685-690, 2009
4)Ueta M, Sotozono C, Nakano M et al:Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study. J Allergy Clin Immunol 126:1218-1225, 2010
5)Ueta M, Sotozono C, Inatomi T et al:Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol 91:962-965, 2007
6)Ueta M, Tamiya G, Tokunaga K et al:Epistatic interaction between Toll-like receptor 3(TLR3)and prostaglandin E receptor 3(PTGER3)genes. J Allergy Clin Immunol 129:1413-1416, 2012
7)Ueta M, Kinoshita S:Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res 31:551-575, 2012
infections in the cornea. Cornea 21:S94-S101, 2002
9)Yagi T, Sotozono C, Tanaka M et al:Cytokine storm arising on the ocular surface in a patient with Stevens-Johnson syndrome. Br J Ophthalmol 95:1030-1031, 2011
10)木下 茂・小泉範子・外園千恵・他:角膜疾患の未来医療.日眼会誌 114:161-201,2010
11)Sotozono C, Inatomi T, Nakamura T et al:Visual improvement after cultivated oral mucosal epithelial transplantation. Ophthalmology 120:193-200, 2013